Product References
In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies.
Communications biology
Fritzwanker S,Nagel F,Kliewer A,Stammer V,Schulz S
Sat Apr 15 00:00:00 EDT 2023
Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
Science signaling
Miess E,Gondin AB,Yousuf A,Steinborn R,Mösslein N,Yang Y,Göldner M,Ruland JG,Bünemann M,Krasel C,Christie MJ,Halls ML,Schulz S,Canals M
Tue Jul 17 00:00:00 EDT 2018
Role of Phosphorylation Sites in Desensitization of µ-Opioid Receptor.
Molecular pharmacology
Yousuf A,Miess E,Sianati S,Du YP,Schulz S,Christie MJ
Thu Oct 01 00:00:00 EDT 2015
Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C.
British journal of pharmacology
Illing S,Mann A,Schulz S
Sat Mar 01 00:00:00 EST 2014
Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Biological psychiatry
Glück L,Loktev A,Moulédous L,Mollereau C,Law PY,Schulz S
Sat Nov 15 00:00:00 EST 2014
Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor.
Molecular endocrinology (Baltimore, Md.)
Petrich A,Mann A,Kliewer A,Nagel F,Strigli A,Märtens JC,Pöll F,Schulz S
Mon Apr 01 00:00:00 EDT 2013
Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor.
Molecular endocrinology (Baltimore, Md.)
Petrich A,Mann A,Kliewer A,Nagel F,Strigli A,Märtens JC,Pöll F,Schulz S
Mon Apr 01 00:00:00 EDT 2013
Differentiation of opioid drug effects by hierarchical multi-site phosphorylation.
Molecular pharmacology
Just S,Illing S,Trester-Zedlitz M,Lau EK,Kotowski SJ,Miess E,Mann A,Doll C,Trinidad JC,Burlingame AL,von Zastrow M,Schulz S
Fri Mar 01 00:00:00 EST 2013
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.
The Journal of clinical endocrinology and metabolism
Casar-Borota O,Heck A,Schulz S,Nesland JM,Ramm-Pettersen J,Lekva T,Alafuzoff I,Bollerslev J
Fri Nov 01 00:00:00 EDT 2013
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.
The Journal of clinical endocrinology and metabolism
Casar-Borota O,Heck A,Schulz S,Nesland JM,Ramm-Pettersen J,Lekva T,Alafuzoff I,Bollerslev J
Fri Nov 01 00:00:00 EDT 2013
Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.
British journal of pharmacology
Doll C,Pöll F,Peuker K,Loktev A,Glück L,Schulz S
Thu Nov 01 00:00:00 EDT 2012
Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.
British journal of pharmacology
Doll C,Konietzko J,Pöll F,Koch T,Höllt V,Schulz S
Thu Sep 01 00:00:00 EDT 2011
Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience
Grecksch G,Just S,Pierstorff C,Imhof AK,Glück L,Doll C,Lupp A,Becker A,Koch T,Stumm R,Höllt V,Schulz S
Wed Sep 28 00:00:00 EDT 2011
Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
Neuroendocrinology
Lupp A,Hunder A,Petrich A,Nagel F,Doll C,Schulz S
Wed Mar 21 00:00:00 EDT 2012
Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
Neuroendocrinology
Lupp A,Hunder A,Petrich A,Nagel F,Doll C,Schulz S
Wed Mar 21 00:00:00 EDT 2012
Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
Neuroendocrinology
Lupp A,Hunder A,Petrich A,Nagel F,Doll C,Schulz S
Wed Mar 21 00:00:00 EDT 2012
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies.
Gut
Kulaksiz H,Eissele R,Rössler D,Schulz S,Höllt V,Cetin Y,Arnold R
Tue Jan 01 00:00:00 EST 2002
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies.
Gut
Kulaksiz H,Eissele R,Rössler D,Schulz S,Höllt V,Cetin Y,Arnold R
Tue Jan 01 00:00:00 EST 2002
Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies.
Gut
Kulaksiz H,Eissele R,Rössler D,Schulz S,Höllt V,Cetin Y,Arnold R
Tue Jan 01 00:00:00 EST 2002
Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.
Clinical cancer research : an official journal of the American Association for Cancer Research
Schulz S,Pauli SU,Schulz S,Händel M,Dietzmann K,Firsching R,Höllt V
Mon May 01 00:00:00 EDT 2000
Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.
Clinical cancer research : an official journal of the American Association for Cancer Research
Schulz S,Pauli SU,Schulz S,Händel M,Dietzmann K,Firsching R,Höllt V
Mon May 01 00:00:00 EDT 2000
Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.
Clinical cancer research : an official journal of the American Association for Cancer Research
Schulz S,Pauli SU,Schulz S,Händel M,Dietzmann K,Firsching R,Höllt V
Mon May 01 00:00:00 EDT 2000